Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $432.49. The company's market cap stands at 233.83B, with a P/E ratio of 26.47 and a dividend yield of 2.33%.
During the trading session on 2026-10-16, Amgen(AMGN) shares reached a daily high of $439.94 and a low of $430.01. At a current price of $432.49, the stock is +0.6% higher than the low and still -1.7% under the high.
Trading volume for Amgen(AMGN) stock has reached 2.57M, versus its average volume of 2.66M.
The stock's 52-week range extends from a low of $288.00 to a high of $447.03.
The stock's 52-week range extends from a low of $288.00 to a high of $447.03.
AMGN News
Advertisement Why Amgen’s Upcoming Earnings Matter For Investors Amgen (AMGN) heads into its 3 November 2026 earnings release with expectations for a modest u...
Investing AMGN vs. MRK: Which Pharma Giant’s Dividend Actually Has Room to Grow Amgen and Merck both yield around 2.3% and have surged this year, but one of the...
Investing How to Turn $500,000 Into a Lazy $16,500 Yearly Passive Income Stream Retirees watching CD rates scrape bottom and Treasury coupons lock in for a deca...
Analyst ratings
51%
of 37 ratingsMore AMGN News
Investing Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying Every big pharma company eventually watches its best-selling drug go generic...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has launched a new Phase 1 study that looks at how its bone drug romoso...
Guggenheim analyst Vamil Divan lowered the firm’s price target on Amgen (AMGN) to $378 from $388 and keeps a Neutral rating on the shares as the firm updated it...
BMO Capital lowered the firm’s price target on Amgen (AMGN) to $415 from $450 and keeps a Market Perform rating on the shares as part of a broader research note...
BofA analyst Tazeen Ahmad raised the firm’s price target on Amgen (AMGN) to $328 from $317 and keeps an Underperform rating on the shares after updating estimat...
Wells Fargo lowered the firm’s price target on Amgen (AMGN) to $430 from $435 following pipeline valuation updates, while keeping an Equal Weight rating on the...
has delivered a powerful run in recent years, and the question now is whether the current share price lines up with the cash flows that underpin the business. W...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.